At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Atomoxetine +1 moredrug
Likely dose
Atomoxetine 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
In Brief
A clinical study evaluating Atomoxetine and Sugar Pill for Addiction. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects of atomoxetine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAddiction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedDec 2011
Primary CompletionJul 2013
TodayJul 2026
First PostedDec 23, 2011
Enrollment StartDec 1, 2011
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 14.5 years ago
Interventions
Atomoxetinedrug
Atomoxetine 40mg and 80mg compared to the sugar pill
Sugar Pilldrug
Sugar pill compared to Atomoxetine 40mg and 80mg.